Literature DB >> 32201334

A familial PLCB4 mutation causing auriculocondylar syndrome 2 with variable severity.

Amira Nabil1, Sahar El Shafei2, Nihal M El Shakankiri3, Ahmed Habib4, Heba Morsy2, Sateesh Maddirevula5, Fowzan S Alkuraya6.   

Abstract

Auriculocondylar syndrome (ARCND, MIM #614669, #602483, and #615706); also known as ''question-mark ear syndrome'' or ''dysgnathia complex'', is a rare craniofacial malformation of first and second branchial arches with a prevalence of <1/1,000,000. It is characterized by a distinctive auricular malformation (question mark ear (QME)) and highly variable mandibular anomalies. Variants found in PLCB4, GNAI3, and in EDN1 genes are responsible for >90% of tested ARCND patients. Whole exome sequencing in a multigenerational Egyptian kindred with high intrafamilial variability revealed a known heterozygous missense variant in PLCB4 (NM_000933.3:c.1862G>A:p.(Arg621His)). This report increases the number of molecularly characterized ARCND patients to 29 and emphasizes the highly variable clinical presentation within families.
Copyright © 2020 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  ARCND; Familial; Mandibular to maxillary transformation; PLCB4; Variability

Mesh:

Substances:

Year:  2020        PMID: 32201334     DOI: 10.1016/j.ejmg.2020.103917

Source DB:  PubMed          Journal:  Eur J Med Genet        ISSN: 1769-7212            Impact factor:   2.708


  6 in total

Review 1.  Genomics in Egypt: Current Status and Future Aspects.

Authors:  Eman Ahmed El-Attar; Rasha Mohamed Helmy Elkaffas; Sarah Ahmed Aglan; Iman S Naga; Amira Nabil; Hoda Y Abdallah
Journal:  Front Genet       Date:  2022-05-13       Impact factor: 4.772

2.  Further phenotypic delineation of the auriculocondylar syndrome type 2 with literature review.

Authors:  Ewelina Bukowska-Olech; Anna Sowińska-Seidler; Filip Łojek; Delfina Popiel; Joanna Walczak-Sztulpa; Aleksander Jamsheer
Journal:  J Appl Genet       Date:  2020-10-31       Impact factor: 3.240

3.  The Polymorphism at PLCB4 Promoter (rs6086746) Changes the Binding Affinity of RUNX2 and Affects Osteoporosis Susceptibility: An Analysis of Bioinformatics-Based Case-Control Study and Functional Validation.

Authors:  Dung-Jang Tsai; Wen-Hui Fang; Li-Wei Wu; Ming-Cheng Tai; Chung-Cheng Kao; Shih-Ming Huang; Wei-Teing Chen; Po-Jen Hsiao; Chih-Chien Chiu; Wen Su; Chia-Chun Wu; Sui-Lung Su
Journal:  Front Endocrinol (Lausanne)       Date:  2021-11-25       Impact factor: 5.555

4.  Mir24-2-5p suppresses the osteogenic differentiation with Gnai3 inhibition presenting a direct target via inactivating JNK-p38 MAPK signaling axis.

Authors:  Li Meng; Lichan Yuan; Jieli Ni; Mengru Fang; Shuyu Guo; Huayang Cai; Jinwei Qin; Qi Cai; Mengnan Zhang; Fang Hu; Junqing Ma; Yang Zhang
Journal:  Int J Biol Sci       Date:  2021-10-17       Impact factor: 6.580

5.  Clinical Profiles and Genetic Spectra of 814 Chinese Children With Short Stature.

Authors:  Xin Li; Ruen Yao; Guoying Chang; Qun Li; Cui Song; Niu Li; Yu Ding; Juan Li; Yao Chen; Yirou Wang; Xiaodong Huang; Yongnian Shen; Hao Zhang; Jian Wang; Xiumin Wang
Journal:  J Clin Endocrinol Metab       Date:  2022-03-24       Impact factor: 5.958

6.  Auriculocondylar syndrome 2 results from the dominant-negative action of PLCB4 variants.

Authors:  Stanley M Kanai; Caleb Heffner; Timothy C Cox; Michael L Cunningham; Francisco A Perez; Aaron M Bauer; Philip Reigan; Cristan Carter; Stephen A Murray; David E Clouthier
Journal:  Dis Model Mech       Date:  2022-04-29       Impact factor: 5.732

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.